Press Releases Choose Year All Items 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 Search Press Releases Found 86 Results August 5, 2021 Surrozen to Present at Canaccord Genuity’s 41st Annual Growth Conference July 9, 2021 Surrozen Presents New Data Demonstrating Superior Activity of SZN-1326 in Preclinical Inflammatory Bowel Disease Models at 16th Congress of the European Crohn’s and Colitis Organisation (ECCO) June 25, 2021 Surrozen Presents Data at 2021 International Liver Conference for Wnt-Modulating Antibody SZN-043 June 17, 2021 Surrozen Presents Data Supporting Potential of SZN-043 at The Liver Biology Conference: Fundamental Mechanisms and Translational Applications June 1, 2021 Surrozen Publishes Article in Nature Communications Demonstrating Selective Wnt Mimetics Stimulate Bone Mass Accrual in Disease Models of Osteoporosis,Aging and Long-Bone Fracture May 24, 2021 Surrozen Presents Data from Lead Wnt-Modulating Antibody Programs, SZN-1326 and SZN-043,in Six Oral and Poster Presentations at 2021 Digestive Disease Week Conference May 6, 2021 Surrozen Strengthens Board of Directors with Appointments of Mace Rothenberg, M.D.,and Christopher Chai April 15, 2021 Surrozen and Consonance-HFW Acquisition Corp. Announce Business Combination, Creating Publicly Listed Leader in Wnt Biology and Tissue Regeneration March 11, 2021 Surrozen Expands Board of Directors with Appointment of Mary Haak-Frendscho,Ph.D. February 2, 2021 Surrozen Expands Board of Directors with Appointment of Shao-Lee Lin, M.D.,Ph.D. «...56789»